Breast Biopsy Market Size and Share Forecast Outlook 2025 to 2035

The Breast Biopsy Market is estimated to be valued at USD 2.5 billion in 2025 and is projected to reach USD 4.2 billion by 2035, registering a compound annual growth rate (CAGR) of 5.3% over the forecast period.

Quick Stats for Breast Biopsy Market

  • Breast Biopsy Market Value (2025): USD 2.5 billion
  • Breast Biopsy Market Forecast Value (2035): USD 4.2 billion
  • Breast Biopsy Market Forecast CAGR: 5.3%
  • Leading Segment in Breast Biopsy Market in 2025: Vacuum-Assisted Device (VAD) (28.9%)
  • Key Growth Regions in Breast Biopsy Market: North America, Asia-Pacific, Europe
  • Top Key Players in Breast Biopsy Market: Hologic, Inc., Becton, Dickinson and Company, Danaher Corporation, Merit Medical Systems, Medtronic, IZI Medical Products, Argon Medical, STERYLAB S.r.l., Scion Medical Technologies LLC, QIAGEN, Biocept Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd.
Breast Biopsy Market Market Value Analysis

Breast Biopsy Market Key Takeaways

Metric Value
Breast Biopsy Market Estimated Value in (2025 E) USD 2.5 billion
Breast Biopsy Market Forecast Value in (2035 F) USD 4.2 billion
Forecast CAGR (2025 to 2035) 5.3%

Why is the Breast Biopsy Market Growing?

The breast biopsy market is witnessing consistent expansion, driven by rising global incidence of breast cancer and the growing emphasis on early detection and accurate diagnosis. Increasing patient awareness, improved access to screening programs, and the availability of minimally invasive diagnostic tools are influencing demand patterns. Technological advancements in imaging-guided biopsy procedures, including ultrasound, MRI, and stereotactic techniques, are improving accuracy while reducing procedural risks, which is further supporting adoption.

Hospitals and specialized diagnostic centers are expanding investments in advanced biopsy equipment to ensure precision in both detection and tissue characterization. Regulatory frameworks across regions are also placing greater importance on early-stage detection to improve survival rates, which in turn is driving the integration of advanced biopsy solutions into clinical practice.

As global healthcare infrastructure strengthens and demand for accurate, patient-friendly diagnostic methods continues to grow, the breast biopsy market is positioned for sustained progress The increasing development of targeted therapies and personalized medicine strategies further underscores the importance of accurate biopsy procedures as a critical diagnostic foundation.

Segmental Analysis

The breast biopsy market is segmented by product, indication, end user, and geographic regions. By product, breast biopsy market is divided into Vacuum-Assisted Device (VAD), Guide Wire (Localization Wire), Breast Biopsy Marker, Biopsy Needle, MRI-Guide Biopsy Systems, and Ultrasound Guided Breast Biopsy Systems. In terms of indication, breast biopsy market is classified into Suspicious solid mass (fibroadenoma), Complex cyst, Solid mass, and Suspicious micro-calcifications. Based on end user, breast biopsy market is segmented into Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Cancer Research Institutes. Regionally, the breast biopsy industry is classified into North America, Latin America, Western Europe, Eastern Europe, Balkan & Baltic Countries, Russia & Belarus, Central Asia, East Asia, South Asia & Pacific, and the Middle East & Africa.

Insights into the Vacuum-Assisted Device Product Segment

Breast Biopsy Market Analysis By Product

The vacuum-assisted device segment is projected to account for 28.9% of the breast biopsy market revenue share in 2025, making it the leading product category. Its adoption is being driven by the ability to collect larger and higher-quality tissue samples in a single insertion, which improves diagnostic accuracy and reduces the need for repeat procedures. Minimally invasive characteristics, shorter procedure times, and reduced scarring are increasing patient preference for this device type.

Healthcare providers are adopting vacuum-assisted devices due to their capability to support both diagnosis and small lesion removal, thereby offering dual clinical utility. Continuous advancements in device design, including enhanced needle systems and compatibility with imaging guidance, are reinforcing their use in complex diagnostic scenarios.

Cost-effectiveness in terms of reducing repeat biopsies and hospital stays is also contributing to the segment’s leadership As demand for precision medicine and early diagnosis accelerates, vacuum-assisted devices are expected to remain at the forefront of breast biopsy product innovation and adoption.

Insights into the Suspicious Solid Mass (Fibroadenoma) Indication Segment

Breast Biopsy Market Analysis By Indication

The suspicious solid mass indication segment, particularly fibroadenoma, is expected to represent 32.2% of the breast biopsy market revenue share in 2025, establishing it as the leading indication area. This dominance is being reinforced by the high prevalence of fibroadenomas, especially among younger women, and the necessity of biopsy to confirm benignity and rule out malignancy. The segment benefits from the widespread recommendation of tissue sampling for suspicious solid masses, as imaging alone may not provide sufficient diagnostic clarity.

The ability of modern biopsy techniques to provide rapid, minimally invasive, and reliable results is driving their application in this indication. Increased awareness and participation in routine screening programs are leading to the early detection of fibroadenomas, further expanding demand.

Clinicians favor advanced biopsy systems that minimize patient discomfort while maximizing diagnostic confidence, thereby strengthening the adoption of biopsy procedures for this segment With continued focus on early and accurate detection, suspicious solid masses remain a leading driver of procedural volume in the breast biopsy market.

Insights into the Hospitals End-User Segment

Breast Biopsy Market Analysis By End User

The hospitals segment is anticipated to hold 26.9% of the breast biopsy market revenue share in 2025, positioning it as the dominant end-user category. Its leadership is being supported by the availability of advanced imaging and biopsy equipment within hospital settings, which enables comprehensive diagnostic and treatment services under one roof. Hospitals serve as primary centers for cancer screening, diagnosis, and treatment, creating higher patient inflows for biopsy procedures.

Investments in technologically advanced biopsy systems, coupled with specialized oncology departments, are reinforcing the role of hospitals as the preferred setting for accurate diagnosis. The ability to integrate biopsy procedures with surgical and therapeutic interventions is also driving reliance on hospitals for breast cancer management.

Increasing government and private healthcare spending, particularly in developing regions, is strengthening hospital infrastructure and improving access to diagnostic technologies As the demand for precision diagnostics and multidisciplinary cancer care continues to rise, hospitals are expected to maintain their dominant share in the breast biopsy market.

Market Overview

North America Non-invasive Approach creates a Strong Market

The North American region commands the largest market share for breast biopsy, followed by Europe. The breast biopsy market growth in the North American region is aided by the rising incidences of breast cancer and the rising demand for non-invasive treatments.

The European market for breast biopsy is anticipated to grow profitably during the anticipated period. The market for breast biopsy is expected to grow as a result of rising government spending on research studies into breast cancer and the adoption of technologically advanced treatments.

Due to their developing healthcare infrastructure, the regions of Latin America, the Middle East, and Africa are currently experiencing a period of rapid growth.

  • Thermo Fisher Scientific Corp., Becton, Dickinson & Company, Hologic, Inc., Cell-Signalling Technology, Danaher, QIAGEN, Illumina, Fujifilm, Medtronic, Bio-rad, and others are on the list of important players in the market for breast biopsy. A co-exclusive commercial agreement between Becton, a preeminent global medical technology company, and Magnolia Medical Technologies, Inc., was announced today. It aims to assist American hospitals in lowering blood culture contamination in order to increase testing precision and ultimately enhance clinical outcomes.
  • Launch of the Good Morning Gorgeous Sweepstakes by Hologic and Mary J. Blige serves as a wake-up call to raise awareness of the value of preventive care. The sponsorship is Hologic's most recent attempt to emphasize the value of preventive care and well-woman exams.

What are the Factors Responsible for the Growth of the Breast Biopsy Market?

The huge rise in women's susceptibility to mammary cancer, along with screenings and awareness campaigns launched in their favor, are driving the growth of the breast biopsy market. Furthermore, minimally invasive and the development of more accurate treatments for the early detection of breast cancer have benefited to broad and active research environment for breast biopsy. The increasing incidence of breast cancer worldwide and the fact that they are the least invasive procedure will expand market expansion.

Additionally, favorable reimbursements policy and various initiatives taken by the government are increasing the adoption of breast biopsy, which is expected to propel the market in the upcoming year.

Which Region Shows Strong Growth Potential in Breast Biopsy Market?

In the breast biopsy market, the North American region holds the highest market share followed by Europe. The increasing demand for non-invasive treatment and rising incidences of breast cancer will boost the market growth in the North American region.

The European market is expected to show lucrative growth in the forecasted period.

Government investment in breast cancer research studies is increasing as well as the adoption of technologically advanced treatment is anticipated to propel the breast biopsy market. Latin America, the Middle East, and Africa regions are at a blossoming stage and are expected to show sustainable growth in the near future, owing to the developing healthcare infrastructure.

Who are the Key Manufacturers of the Breast Biopsy Market?

Breast Biopsy Market Analysis By Company

Hologic, Inc., Becton, Dickinson, and Company, Danaher Corporation, Merit Medical Systems, Medtronic, IZI Medical Products, Argon Medical, STERYLAB S.r.l., Scion Medical Technologies LLC, QIAGEN, Biocept Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd.

Analysis of Breast Biopsy Market By Key Countries

Breast Biopsy Market Cagr Analysis By Country

Country CAGR
China 7.2%
India 6.6%
Germany 6.1%
France 5.6%
UK 5.0%
USA 4.5%
Brazil 4.0%

Country-wise Analysis

The Breast Biopsy Market is expected to register a CAGR of 5.3% during the forecast period, exhibiting varied country level momentum. China leads with the highest CAGR of 7.2%, followed by India at 6.6%. Developed markets such as Germany, France, and the UK continue to expand steadily, while the USA is likely to grow at consistent rates. Brazil posts the lowest CAGR at 4.0%, yet still underscores a broadly positive trajectory for the global Breast Biopsy Market. In 2024, Germany held a dominant revenue in the Western Europe market and is expected to grow with a CAGR of 6.1%. The USA Breast Biopsy Market is estimated to be valued at USD 858.4 million in 2025 and is anticipated to reach a valuation of USD 1.3 billion by 2035. Sales are projected to rise at a CAGR of 4.5% over the forecast period between 2025 and 2035. While Japan and South Korea markets are estimated to be valued at USD 128.4 million and USD 83.1 million respectively in 2025.

Key Players in the Breast Biopsy Market

  • Hologic, Inc.
  • Becton
  • Dickinson and Company
  • Danaher Corporation
  • Merit Medical Systems
  • Medtronic
  • IZI Medical Products
  • Argon Medical
  • STERYLAB S.r.l.
  • Scion Medical Technologies LLC
  • QIAGEN
  • Biocept Inc.
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd.

Scope of the Report

Item Value
Quantitative Units USD 2.5 Billion
Product Vacuum-Assisted Device (VAD), Guide Wire (Localization Wire), Breast Biopsy Marker, Biopsy Needle, MRI-Guide Biopsy Systems, and Ultrasound Guided Breast Biopsy Systems
Indication Suspicious solid mass (fibroadenoma), Complex cyst, Solid mass, and Suspicious micro-calcifications
End User Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Cancer Research Institutes
Regions Covered North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country Covered United States, Canada, Germany, France, United Kingdom, China, Japan, India, Brazil, South Africa
Key Companies Profiled Hologic, Inc., Becton, Dickinson and Company, Danaher Corporation, Merit Medical Systems, Medtronic, IZI Medical Products, Argon Medical, STERYLAB S.r.l., Scion Medical Technologies LLC, QIAGEN, Biocept Inc., Bio-Rad Laboratories, Inc., and F. Hoffmann-La Roche Ltd.

Breast Biopsy Market by Segments

Product:

  • Vacuum-Assisted Device (VAD)
  • Guide Wire (Localization Wire)
  • Breast Biopsy Marker
  • Biopsy Needle
  • MRI-Guide Biopsy Systems
  • Ultrasound Guided Breast Biopsy Systems

Indication:

  • Suspicious solid mass (fibroadenoma)
  • Complex cyst
  • Solid mass
  • Suspicious micro-calcifications

End User:

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Cancer Research Institutes

Region:

  • North America
    • USA
    • Canada
    • Mexico
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Western Europe
    • Germany
    • UK
    • Italy
    • Spain
    • France
    • Nordic
    • BENELUX
    • Rest of Western Europe
  • Eastern Europe
    • Russia
    • Poland
    • Hungary
    • Balkan & Baltic
    • Rest of Eastern Europe
  • East Asia
    • China
    • Japan
    • South Korea
  • South Asia and Pacific
    • India
    • ASEAN
    • Australia & New Zealand
    • Rest of South Asia and Pacific
  • Middle East & Africa
    • Kingdom of Saudi Arabia
    • Other GCC Countries
    • Turkiye
    • South Africa
    • Other African Union
    • Rest of Middle East & Africa

Table of Content

  1. Executive Summary
    • Global Market Outlook
    • Demand-side Trends
    • Supply-side Trends
    • Technology Roadmap Analysis
    • Analysis and Recommendations
  2. Market Overview
    • Market Coverage / Taxonomy
    • Market Definition / Scope / Limitations
  3. Market Background
    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunity
      • Trends
    • Scenario Forecast
      • Demand in Optimistic Scenario
      • Demand in Likely Scenario
      • Demand in Conservative Scenario
    • Opportunity Map Analysis
    • Product Life Cycle Analysis
    • Supply Chain Analysis
    • Investment Feasibility Matrix
    • Value Chain Analysis
    • PESTLE and Porter’s Analysis
    • Regulatory Landscape
    • Regional Parent Market Outlook
    • Production and Consumption Statistics
    • Import and Export Statistics
  4. Global Market Analysis 2020 to 2024 and Forecast, 2025 to 2035
    • Historical Market Size Value (USD Million) Analysis, 2020 to 2024
    • Current and Future Market Size Value (USD Million) Projections, 2025 to 2035
      • Y-o-Y Growth Trend Analysis
      • Absolute $ Opportunity Analysis
  5. Global Market Pricing Analysis 2020 to 2024 and Forecast 2025 to 2035
  6. Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Product
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By Product , 2020 to 2024
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By Product , 2025 to 2035
      • Vacuum-Assisted Device (VAD)
      • Guide Wire (Localization Wire)
      • Marker
      • Biopsy Needle
        • Core Needles
        • Fine Aspiration Needles
      • MRI-Guide Biopsy Systems
      • Ultrasound Guided Systems
        • Two-Dimensional (2-D) Mammographic Ultrasonic Scanning Systems
        • Three-Dimensional (3-D) B-Mode Mammographic Ultrasonic Scanning Systems
    • Y-o-Y Growth Trend Analysis By Product , 2020 to 2024
    • Absolute $ Opportunity Analysis By Product , 2025 to 2035
  7. Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Indication
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By Indication, 2020 to 2024
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By Indication, 2025 to 2035
      • Suspicious solid mass (fibroadenoma)
      • Complex cyst
      • Solid mass
      • Suspicious micro-calcifications
    • Y-o-Y Growth Trend Analysis By Indication, 2020 to 2024
    • Absolute $ Opportunity Analysis By Indication, 2025 to 2035
  8. Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By End User
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By End User, 2020 to 2024
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By End User, 2025 to 2035
      • Hospitals
      • Specialty Clinics
      • Ambulatory Surgical Centers
      • Cancer Research Institutes
    • Y-o-Y Growth Trend Analysis By End User, 2020 to 2024
    • Absolute $ Opportunity Analysis By End User, 2025 to 2035
  9. Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Region
    • Introduction
    • Historical Market Size Value (USD Million) Analysis By Region, 2020 to 2024
    • Current Market Size Value (USD Million) Analysis and Forecast By Region, 2025 to 2035
      • North America
      • Latin America
      • Western Europe
      • Eastern Europe
      • East Asia
      • South Asia and Pacific
      • Middle East & Africa
    • Market Attractiveness Analysis By Region
  10. North America Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2020 to 2024
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2025 to 2035
      • By Country
        • USA
        • Canada
        • Mexico
      • By Product
      • By Indication
      • By End User
    • Market Attractiveness Analysis
      • By Country
      • By Product
      • By Indication
      • By End User
    • Key Takeaways
  11. Latin America Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2020 to 2024
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2025 to 2035
      • By Country
        • Brazil
        • Chile
        • Rest of Latin America
      • By Product
      • By Indication
      • By End User
    • Market Attractiveness Analysis
      • By Country
      • By Product
      • By Indication
      • By End User
    • Key Takeaways
  12. Western Europe Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2020 to 2024
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2025 to 2035
      • By Country
        • Germany
        • UK
        • Italy
        • Spain
        • France
        • Nordic
        • BENELUX
        • Rest of Western Europe
      • By Product
      • By Indication
      • By End User
    • Market Attractiveness Analysis
      • By Country
      • By Product
      • By Indication
      • By End User
    • Key Takeaways
  13. Eastern Europe Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2020 to 2024
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2025 to 2035
      • By Country
        • Russia
        • Poland
        • Hungary
        • Balkan & Baltic
        • Rest of Eastern Europe
      • By Product
      • By Indication
      • By End User
    • Market Attractiveness Analysis
      • By Country
      • By Product
      • By Indication
      • By End User
    • Key Takeaways
  14. East Asia Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2020 to 2024
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2025 to 2035
      • By Country
        • China
        • Japan
        • South Korea
      • By Product
      • By Indication
      • By End User
    • Market Attractiveness Analysis
      • By Country
      • By Product
      • By Indication
      • By End User
    • Key Takeaways
  15. South Asia and Pacific Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2020 to 2024
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2025 to 2035
      • By Country
        • India
        • ASEAN
        • Australia & New Zealand
        • Rest of South Asia and Pacific
      • By Product
      • By Indication
      • By End User
    • Market Attractiveness Analysis
      • By Country
      • By Product
      • By Indication
      • By End User
    • Key Takeaways
  16. Middle East & Africa Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2020 to 2024
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2025 to 2035
      • By Country
        • Kingdom of Saudi Arabia
        • Other GCC Countries
        • Turkiye
        • South Africa
        • Other African Union
        • Rest of Middle East & Africa
      • By Product
      • By Indication
      • By End User
    • Market Attractiveness Analysis
      • By Country
      • By Product
      • By Indication
      • By End User
    • Key Takeaways
  17. Key Countries Market Analysis
    • USA
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Product
        • By Indication
        • By End User
    • Canada
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Product
        • By Indication
        • By End User
    • Mexico
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Product
        • By Indication
        • By End User
    • Brazil
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Product
        • By Indication
        • By End User
    • Chile
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Product
        • By Indication
        • By End User
    • Germany
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Product
        • By Indication
        • By End User
    • UK
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Product
        • By Indication
        • By End User
    • Italy
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Product
        • By Indication
        • By End User
    • Spain
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Product
        • By Indication
        • By End User
    • France
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Product
        • By Indication
        • By End User
    • India
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Product
        • By Indication
        • By End User
    • ASEAN
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Product
        • By Indication
        • By End User
    • Australia & New Zealand
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Product
        • By Indication
        • By End User
    • China
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Product
        • By Indication
        • By End User
    • Japan
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Product
        • By Indication
        • By End User
    • South Korea
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Product
        • By Indication
        • By End User
    • Russia
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Product
        • By Indication
        • By End User
    • Poland
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Product
        • By Indication
        • By End User
    • Hungary
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Product
        • By Indication
        • By End User
    • Kingdom of Saudi Arabia
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Product
        • By Indication
        • By End User
    • Turkiye
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Product
        • By Indication
        • By End User
    • South Africa
      • Pricing Analysis
      • Market Share Analysis, 2024
        • By Product
        • By Indication
        • By End User
  18. Market Structure Analysis
    • Competition Dashboard
    • Competition Benchmarking
    • Market Share Analysis of Top Players
      • By Regional
      • By Product
      • By Indication
      • By End User
  19. Competition Analysis
    • Competition Deep Dive
      • Hologic, Inc.
        • Overview
        • Product Portfolio
        • Profitability by Market Segments (Product/Age /Sales Channel/Region)
        • Sales Footprint
        • Strategy Overview
          • Marketing Strategy
          • Product Strategy
          • Channel Strategy
      • Becton
      • Dickinson and Company
      • Danaher Corporation
      • Merit Medical Systems
      • Medtronic
      • IZI Medical Products
      • Argon Medical
      • STERYLAB S.r.l.
      • Scion Medical Technologies LLC
      • QIAGEN
      • Biocept Inc.
      • Bio-Rad Laboratories, Inc.
      • F. Hoffmann-La Roche Ltd.
  20. Assumptions & Acronyms Used
  21. Research Methodology

List of Tables

  • Table 1: Global Market Value (USD Million) Forecast by Region, 2020-2035
  • Table 2: Global Market Value (USD Million) Forecast by Product , 2020-2035
  • Table 3: Global Market Value (USD Million) Forecast by Indication, 2020-2035
  • Table 4: Global Market Value (USD Million) Forecast by End User, 2020-2035
  • Table 5: North America Market Value (USD Million) Forecast by Country, 2020-2035
  • Table 6: North America Market Value (USD Million) Forecast by Product , 2020-2035
  • Table 7: North America Market Value (USD Million) Forecast by Indication, 2020-2035
  • Table 8: North America Market Value (USD Million) Forecast by End User, 2020-2035
  • Table 9: Latin America Market Value (USD Million) Forecast by Country, 2020-2035
  • Table 10: Latin America Market Value (USD Million) Forecast by Product , 2020-2035
  • Table 11: Latin America Market Value (USD Million) Forecast by Indication, 2020-2035
  • Table 12: Latin America Market Value (USD Million) Forecast by End User, 2020-2035
  • Table 13: Western Europe Market Value (USD Million) Forecast by Country, 2020-2035
  • Table 14: Western Europe Market Value (USD Million) Forecast by Product , 2020-2035
  • Table 15: Western Europe Market Value (USD Million) Forecast by Indication, 2020-2035
  • Table 16: Western Europe Market Value (USD Million) Forecast by End User, 2020-2035
  • Table 17: Eastern Europe Market Value (USD Million) Forecast by Country, 2020-2035
  • Table 18: Eastern Europe Market Value (USD Million) Forecast by Product , 2020-2035
  • Table 19: Eastern Europe Market Value (USD Million) Forecast by Indication, 2020-2035
  • Table 20: Eastern Europe Market Value (USD Million) Forecast by End User, 2020-2035
  • Table 21: East Asia Market Value (USD Million) Forecast by Country, 2020-2035
  • Table 22: East Asia Market Value (USD Million) Forecast by Product , 2020-2035
  • Table 23: East Asia Market Value (USD Million) Forecast by Indication, 2020-2035
  • Table 24: East Asia Market Value (USD Million) Forecast by End User, 2020-2035
  • Table 25: South Asia and Pacific Market Value (USD Million) Forecast by Country, 2020-2035
  • Table 26: South Asia and Pacific Market Value (USD Million) Forecast by Product , 2020-2035
  • Table 27: South Asia and Pacific Market Value (USD Million) Forecast by Indication, 2020-2035
  • Table 28: South Asia and Pacific Market Value (USD Million) Forecast by End User, 2020-2035
  • Table 29: Middle East & Africa Market Value (USD Million) Forecast by Country, 2020-2035
  • Table 30: Middle East & Africa Market Value (USD Million) Forecast by Product , 2020-2035
  • Table 31: Middle East & Africa Market Value (USD Million) Forecast by Indication, 2020-2035
  • Table 32: Middle East & Africa Market Value (USD Million) Forecast by End User, 2020-2035

List of Figures

  • Figure 1: Global Market Pricing Analysis
  • Figure 2: Global Market Value (USD Million) Forecast 2020-2035
  • Figure 3: Global Market Value (USD Million) Share and BPS Analysis by Region, 2025 and 2035
  • Figure 4: Global Market Y-o-Y Growth Comparison by Region, 2025-2035
  • Figure 5: Global Market Attractiveness Analysis by Region
  • Figure 6: North America Market Incremental Dollar Opportunity, 2025-2035
  • Figure 7: Latin America Market Incremental Dollar Opportunity, 2025-2035
  • Figure 8: Western Europe Market Incremental Dollar Opportunity, 2025-2035
  • Figure 9: Eastern Europe Market Incremental Dollar Opportunity, 2025-2035
  • Figure 10: East Asia Market Incremental Dollar Opportunity, 2025-2035
  • Figure 11: South Asia and Pacific Market Incremental Dollar Opportunity, 2025-2035
  • Figure 12: Middle East & Africa Market Incremental Dollar Opportunity, 2025-2035
  • Figure 13: North America Market Value Share and BPS Analysis by Country, 2025 and 2035
  • Figure 14: Latin America Market Value Share and BPS Analysis by Country, 2025 and 2035
  • Figure 15: Western Europe Market Value Share and BPS Analysis by Country, 2025 and 2035
  • Figure 16: Eastern Europe Market Value Share and BPS Analysis by Country, 2025 and 2035
  • Figure 17: East Asia Market Value Share and BPS Analysis by Country, 2025 and 2035
  • Figure 18: South Asia and Pacific Market Value Share and BPS Analysis by Country, 2025 and 2035
  • Figure 19: Middle East & Africa Market Value Share and BPS Analysis by Country, 2025 and 2035
  • Figure 20: Global Market - Tier Structure Analysis
  • Figure 21: Global Market - Company Share Analysis

Frequently Asked Questions

How big is the breast biopsy market in 2025?

The global breast biopsy market is estimated to be valued at USD 2.5 billion in 2025.

What will be the size of breast biopsy market in 2035?

The market size for the breast biopsy market is projected to reach USD 4.2 billion by 2035.

How much will be the breast biopsy market growth between 2025 and 2035?

The breast biopsy market is expected to grow at a 5.3% CAGR between 2025 and 2035.

What are the key product types in the breast biopsy market?

The key product types in breast biopsy market are vacuum-assisted device (vad), guide wire (localization wire), breast biopsy marker, biopsy needle, _core needles, _fine aspiration needles, mri-guide biopsy systems, ultrasound guided breast biopsy systems, _two-dimensional (2-d) mammographic ultrasonic scanning systems and _three-dimensional (3-d) b-mode mammographic ultrasonic scanning systems.

Which indication segment to contribute significant share in the breast biopsy market in 2025?

In terms of indication, suspicious solid mass (fibroadenoma) segment to command 32.2% share in the breast biopsy market in 2025.

Explore Similar Insights

Future Market Insights

Breast Biopsy Market

Chat With MaRIA

Chat With

MaRIA

Hi There, I am MaRIA, Your Market Research Intelligence Assistant. How may I help you?